| Authors: |
Pizzarella D; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Kofides A; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Hatcher JM; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Liu X; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Guijosa A; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Tsakmaklis N; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Peachey AL; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Wang J; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA., Guerrera ML; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Patterson CJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Hunter ZR; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Sun H; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Sarosiek SR; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Castillo JJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Buhrlage SJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA., Dhe-Paganon S; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA., Branagan AR; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Treon SP; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Liu S; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. |
